Accustem Sciences Inc. (ACUT)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Income | -$1.76M | -$1.51M | -$2.05M | -$3.75M | -$670.6K | — |
| Net Income | -$1.76M | -$1.51M | -$2.05M | -$3.75M | -$670.6K | — |
| EPS (Diluted) | $-0.12 | $-0.13 | $-0.18 | $-0.34 | $-0.07 | — |
| Total Assets | $1.55M | $50.9K | $133.9K | $939.7K | $1.35M | — |
| Total Liabilities | $4.95M | $3.36M | $2.25M | $1.08M | $702.7K | — |
| Shareholders' Equity | -$3.40M | -$3.31M | -$2.11M | -$139.6K | $650.7K | $1.31M |
| Operating Cash Flow | -$850.4K | -$664.1K | -$1.62M | -$1.81M | — | — |
| Capital Expenditures | — | — | — | $11.0K | — | — |
| Shares Outstanding | 16.07M | 12.10M | 11.35M | 11.35M | 10.00M | — |